Stock report · Delisted · NYSE
Paragon 28 Inc (FNA)
13.09USD Delisted Final close · Apr 16, 2025
FNA no longer trades. Paragon 28 was acquired by Zimmer Biomet (ZBH) in April 2025.
All prices on this page are historical. The last trade was on April 16, 2025, at $13.09.
FNA stock price history
Final trading statistics
- Final close
- $13.09
- Final trading day
- Apr 16, 2025
- Market cap at delisting
- $1.10B
- Shares outstanding
- 83.94M
- Final 52-week range
- $4.65 – $13.13
- Avg. volume (final 3 mo.)
- 2,074,723
- All-time high
- $25.09 · Nov 2021
- All-time low
- $4.78 · Oct 2024
- Return since IPO
- -30.0%
- Beta
- 1.47
- Book value / share
- $1.56
- Price / book
- 8.41
About Paragon 28 Inc
Paragon 28 developed and sold surgical systems for the foot and ankle in the U.S. and abroad. Its forefoot products included the Gorilla plating systems, Phantom nail systems, the Bun-Yo-Matic clamp and MIS screws. Fracture products included ankle plating, Monster screws, Monkey Bars external fixation, R3Flex syndesmotic repair and the Phantom fibula nail.
It also sold flatfoot systems, ankle replacement and fusion products, Charcot reconstruction systems, and orthobiologics such as V92 cellular bone matrix, PRESERVE bone wedges, MgNum bone void filler and BEAST bone matrix. Hospitals, surgery centers and other facilities bought through sales reps and stocking distributors.
The company was founded in 2010 and based in Englewood, Colorado. Zimmer Biomet (ZBH) acquired it in April 2025 for $13.00 in cash per share, and it became a Zimmer Biomet subsidiary as of April 21, 2025. The last trade was on April 16, 2025 at $13.09.
- Exchange (former)
- NYSE
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Englewood, CO
- Employees
- 525
- IPO date
- October 15, 2021
- Delisted
- April 16, 2025
- SEC CIK
- 1531978
Paragon 28 financials before the delisting
The last 5 fiscal years Paragon 28 reported as a public company, fiscal year ending December.
FNA revenue and net income
FNA earnings per share
FNA annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $256.18M | −$54.6M | −$0.62 |
| FY2023 | $216.39M | −$47.8M | −$0.57 |
| FY2022 | $181.38M | −$67.3M | −$0.53 |
| FY2021 | $147.46M | −$13.7M | −$0.29 |
| FY2020 | $110.98M | $2.7M | $0.00 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Paragon 28 stock FAQ
What happened to Paragon 28 stock?
Paragon 28 was acquired by Zimmer Biomet (ZBH) in April 2025. The final close was $13.09 on April 16, 2025.
What did Paragon 28 shareholders receive?
Each FNA share was converted into $13.00 in cash. The deal was valued at about $1.1 billion.
Can I still buy FNA stock?
No. FNA is no longer listed on the NYSE or any other U.S. exchange; it was removed on April 16, 2025.
What was the last price of FNA?
FNA last closed at $13.09 on April 16, 2025, which valued the company at about $1.10B.
How did Paragon 28 do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Paragon 28 reported revenue of $256.18M and net income of −$54.6M.
When did Paragon 28 go public?
Paragon 28 shares started trading on October 15, 2021.
FNA no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.